Cleared Traditional

ALLIANCE CYTOMEGALOVIRUS IMMEDIATE EARLY ANTIGEN DIRECT IMMUNOFLUORESCENCE ASSAY

K951851 · E.I. Dupont DE Nemours & Co., Inc. · Microbiology
Jul 1996
Decision
460d
Days
Class 2
Risk

About This 510(k) Submission

K951851 is an FDA 510(k) clearance for the ALLIANCE CYTOMEGALOVIRUS IMMEDIATE EARLY ANTIGEN DIRECT IMMUNOFLUORESCENCE ASSAY, a Antigen, Iha, Cytomegalovirus (Class II — Special Controls, product code LJO), submitted by E.I. Dupont DE Nemours & Co., Inc. (Newark, US). The FDA issued a Cleared decision on July 24, 1996, 460 days after receiving the submission on April 21, 1995. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3175.

Submission Details

510(k) Number K951851 FDA.gov
FDA Decision Cleared SESE
Date Received April 21, 1995
Decision Date July 24, 1996
Days to Decision 460 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement

Device Classification

Product Code LJO — Antigen, Iha, Cytomegalovirus
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.3175